MetLife, Inc. (MET) gains on deep earnings beat analysis
MetLife, Inc. (MET) gained after beating earnings and revenue estimates, but the real story is deeper than the headline. This analysis breaks down the quarter’s revenue momentum, net income strength, segment performance, capital strategy, and analyst sentiment behind the stock’s move.
MetLife, Inc. (MET) reported a modest earnings beat, with EPS of $2.78 versus $2.77 expected and revenue of $20.52B versus $19.86B expected. The stronger revenue result, higher net income, and upbeat capital strategy helped shares rise 2.21% on heavier-than-average volume. For investors, the quarter reinforces MetLife’s steady operating momentum and its ability to return capital while maintaining a constructive analyst backdrop.
MetLife, Inc. (MET) beat estimates on both earnings and revenue in its latest quarter. EPS came in at $2.78 versus $2.77 expected, while revenue reached $20.52B against a $19.86B estimate.
MET shares closed at $102.89, a gain of 2.21%, with 5,268,409 shares traded versus a 3,084,571 average. The reaction matched the basic earnings message: modest EPS upside, stronger revenue, and continued confidence in the company’s capital strategy.
Key Takeaways
MET earnings beat estimates on both measures provided: EPS was $2.78 versus $2.77 expected, and revenue was $20.52B versus $19.86B expected.
Revenue increased from $18.88B in the June quarter and $19.07B in March. It remained below the $23.81B reported for December.
The latest quarterly financials show net income of $2.40B, compared with $0.74B in June and $1.19B in March.
Management described broad-based segment growth and highlighted Group Benefits, Retirement and Income Solutions, Asia, Latin America, EMEA, and MetLife Investment Management as parts of its diversified model.
Financial targets cited on the MET earnings call included a 15% to 17% adjusted ROE range, a 12.1% direct expense target for 2026, and a $3B to $4B holding-company cash buffer.
Analyst sentiment remains constructive. The consensus shows 26 Buy ratings, 7 Holds, and no Sell ratings. Recent target changes included increases from UBS, Piper Sandler, TD Cowen, JPMorgan, and Wells Fargo.
Financial Performance: MetLife, Inc. Earnings Analysis
The headline result is clean. MetLife posted $2.78 in EPS against a $2.77 consensus estimate. Revenue reached $20.52B, well above the $19.86B estimate. The revenue beat was more visible than the EPS beat, which means the quarter’s strength extended beyond cost control or capital management.
Sequentially, revenue improved from $18.88B in the quarter ended June 30 and $19.07B in the quarter ended March 31. The December figure was higher at $23.81B, while the prior September quarter produced $16.88B. That pattern places the latest result above the two immediately preceding quarters, but below the December peak.
Net income also strengthened in the quarterly financial series. MetLife reported $2.40B for the latest quarter, versus $0.74B in June and $1.19B in March. The net income figure and the adjusted EPS figure measure different earnings views, so investors should keep the distinction intact rather than treat them as interchangeable.
EPS performance has been consistent across the dated earnings history. The latest $2.78 result topped the $2.43 reported on August 5, the $2.42 reported on May 6, the $2.58 reported on February 4, and the $2.34 reported on November 5, 2025. That record gives the current MET earnings beat more weight than a one-quarter surprise alone.
The operating model rests on two broad groups. Management describes capital-light businesses such as Group Benefits, Latin America, EMEA, and asset management alongside capital-driven retirement and spread-based operations. This structure matters because it links fee income, underwriting income, asset origination, and investment income across the enterprise.
Management also cited a 17% adjusted ROE and a 12.1% direct expense ratio in its operating framework. The ROE figure sits at the top of the stated 15% to 17% annual target range. Meanwhile, the expense target points to continued attention on productivity, especially after the addition of PineBridge Investments.
Capital allocation adds another layer to the result. MetLife announced a new $3B share repurchase authorization and reported $3.4B of cash and liquid assets at its holding companies. It also stated that shareholders had received more than $2.4B through buybacks and common dividends through July. For investors, the combination of earnings growth and capital return remains central to the MET valuation story.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
MET closed at $102.89 after gaining 2.21%. Trading volume reached 5,268,409 shares, compared with an average of 3,084,571. The price move was positive, and the heavier volume gave the reaction more force than a quiet, low-liquidity move.
The analyst backdrop was already favorable before the earnings event. UBS raised its target from $97 to $111 on October 6 while maintaining a Buy rating. Barclays moved from $112 to $109 on October 7 with Outperform maintained. Piper Sandler raised its target from $105 to $110 on September 22 and kept its Buy rating.
Other recent actions were also constructive. TD Cowen raised its target from $110 to $114 on October 21. JPMorgan moved from $108 to $110 on October 15, and Wells Fargo moved from $109 to $110 on October 12. Mizuho lowered its target from $112 to $109 on October 7. The overall pattern shows target changes around a largely positive rating structure, rather than a broad shift toward caution.
The consensus of 26 Buys, 7 Holds, and no Sells supports that reading. However, a positive rating is not the same as a guaranteed stock gain. MetLife’s latest move reflects a favorable earnings print, while future returns still depend on how consistently the company delivers its ROE, expense, investment, and capital-return targets.
CEO Michel Khalaf framed the quarter around the company’s New Frontier strategy. His message focused less on a single product and more on the interaction between capital-light businesses and capital-driven operations.
“At the heart of our New Frontier strategy are 2 complementary earnings engines that contribute roughly equally. One is capital light, where businesses like Group Benefits, Latin America, EMEA and Asset Management generate attractive fee and underwriting income with strong cash generation. The other is capital driven, where our retirement and spread-based businesses leverage our origination, investment and risk management capabilities to put our balance sheet to work at attractive risk-adjusted returns.” - Michel Khalaf, President and CEO, Earnings Call
In plain English, Khalaf is arguing that MetLife does not rely on one earnings lever. Fee income and underwriting provide one base, while retirement products and spread businesses use the balance sheet for another. That diversification gives the strategy a sturdier shape than a simple bet on interest rates or equity markets.
“New Frontier is the right strategy for MetLife, and we are moving forward with speed and purpose.” - Michel Khalaf, President and CEO, Earnings Call
CFO John McCallion supplied the financial guardrails. He pointed to adjusted ROE, expense control, credit conditions, and hedging performance as the key measures supporting the outlook.
“Adjusted EPS grew 20%, while adjusted ROE reached 17% at the top end of our 15% to 17% target range.” - John McCallion, CFO and Head of MetLife Investment Management, Earnings Call
“Our outlook on credit remains stable, and our hedging program continues to perform as expected.” - John McCallion, CFO and Head of MetLife Investment Management, Earnings Call
McCallion also cited the 12.1% direct expense ratio and the 100 to 120 basis point guidance range for total investment spread. Those figures frame the main execution test. MetLife needs to preserve expense discipline while managing investment returns and the balance-sheet demands of retirement products.
Bottom Line
MetLife, Inc. delivered a solid earnings beat, stronger revenue than the prior two quarters, and a constructive capital-return message. The stock’s 2.21% gain and Buy-heavy analyst consensus support the positive read, while the 15% to 17% ROE target and 12.1% expense goal define the standards MET must keep meeting.
For investors, the central issue is execution. If MetLife sustains broad earnings growth while funding buybacks and protecting its expense targets, the New Frontier strategy has a credible path to keep building shareholder value.
+Did MetLife (MET) beat earnings expectations this quarter?
Yes. MetLife reported EPS of $2.78 versus the $2.77 consensus estimate, and revenue of $20.52B versus $19.86B expected.
+Why did MetLife stock rise after earnings?
Shares rose because the company beat on both earnings and revenue, with revenue showing the clearer upside versus estimates. The stock closed at $102.89, up 2.21%, on volume of 5,268,409 shares versus a 3,084,571 average.
+How strong was MetLife's revenue and net income this quarter?
MetLife reported revenue of $20.52B, up from $18.88B in the June quarter and $19.07B in the March quarter, though below the $23.81B December level. Net income came in at $2.40B, compared with $0.74B in June and $1.19B in March.
+What is the outlook for MetLife based on analyst sentiment and capital returns?
Analyst sentiment remains constructive, with 26 Buy ratings, 7 Holds, and no Sell ratings. Management also highlighted a new $3B share repurchase authorization, a $3.4B holding-company cash and liquid asset balance, and a target framework that includes a 15% to 17% adjusted ROE range.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on MET?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.